Find Obefazimod manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Abx-464, Abx464, Obefazimod, 1258453-75-6, Spl-464, Obefazimod [usan]
Molecular Formula
C16H10ClF3N2O
Molecular Weight
338.71  g/mol
InChI Key
OZOGDCZJYVSUBR-UHFFFAOYSA-N
FDA UNII
26RU378B9V

Obefazimod
Obefazimod is an orally available, small molecule binder of the cap binding complex (CBC) 80/20, with potential antiviral and anti-inflammatory activities. Upon oral administration, obefazimod binds to the CBC, a complex at the 5'-end of the pre-mRNA transcript that promotes the initial interaction with transcription and processing machinery. This leads to a conformational change in the CBC and enhanced splicing of viral RNA variants and upregulation of the anti-inflammatory microRNA, miR-124, via splicing of a long noncoding RNA at the miR-124-1 locus. In human immunodeficiency virus type 1 (HIV-1)-infected cells, obefazimod interacts with the CBC of HIV-1 mRNA and inhibits viral replication by preventing Rev-mediated export of unspliced HIV-1 transcripts to the cytoplasm. Rev facilitates the nuclear export of unspliced or incompletely spliced viral pre-mRNAs, an essential step in HIV-1 replication. In inflammatory conditions, miR-124 reduces the production of various inflammatory mediators, including interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), and C-C motif chemokine 2 (CCL2; MCP-1.). miR-124 plays a critical role in innate and adaptive immune responses and is a critical mediator of cholinergic anti-inflammatory action.
1 2D Structure

Obefazimod

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine
2.1.2 InChI
InChI=1S/C16H10ClF3N2O/c17-13-3-1-2-10-4-9-14(22-15(10)13)21-11-5-7-12(8-6-11)23-16(18,19)20/h1-9H,(H,21,22)
2.1.3 InChI Key
OZOGDCZJYVSUBR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC2=C(C(=C1)Cl)N=C(C=C2)NC3=CC=C(C=C3)OC(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
26RU378B9V
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Abx464

2.3.2 Depositor-Supplied Synonyms

1. Abx-464

2. Abx464

3. Obefazimod

4. 1258453-75-6

5. Spl-464

6. Obefazimod [usan]

7. 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine

8. 26ru378b9v

9. 2-quinolinamine, 8-chloro-n-(4-(trifluoromethoxy)phenyl)-

10. Obefazimod [inn]

11. Unii-26ru378b9v

12. Schembl1705888

13. Abx-464 [who-dd]

14. Chembl4297344

15. Gtpl11698

16. Ex-a3322

17. Who 12112

18. Db14828

19. Mmv1581032

20. Sb18690

21. Ac-35811

22. Bs-14770

23. Abx464(abx-464;abx 464)

24. Hy-100870

25. Cs-0020537

26. S0076

27. A16912

28. D84095

29. Q27896117

2.4 Create Date
2011-01-31
3 Chemical and Physical Properties
Molecular Weight 338.71 g/mol
Molecular Formula C16H10ClF3N2O
XLogP35.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass338.0433751 g/mol
Monoisotopic Mass338.0433751 g/mol
Topological Polar Surface Area34.2 Ų
Heavy Atom Count23
Formal Charge0
Complexity388
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Looking for 1258453-75-6 / Obefazimod API manufacturers, exporters & distributors?

Obefazimod manufacturers, exporters & distributors 1

23

PharmaCompass offers a list of Obefazimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Obefazimod manufacturer or Obefazimod supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Obefazimod manufacturer or Obefazimod supplier.

PharmaCompass also assists you with knowing the Obefazimod API Price utilized in the formulation of products. Obefazimod API Price is not always fixed or binding as the Obefazimod Price is obtained through a variety of data sources. The Obefazimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Obefazimod

Synonyms

Abx-464, Abx464, 1258453-75-6, Spl-464, Obefazimod [usan], 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine

Cas Number

1258453-75-6

Unique Ingredient Identifier (UNII)

26RU378B9V

About Obefazimod

Obefazimod is an orally available, small molecule binder of the cap binding complex (CBC) 80/20, with potential antiviral and anti-inflammatory activities. Upon oral administration, obefazimod binds to the CBC, a complex at the 5'-end of the pre-mRNA transcript that promotes the initial interaction with transcription and processing machinery. This leads to a conformational change in the CBC and enhanced splicing of viral RNA variants and upregulation of the anti-inflammatory microRNA, miR-124, via splicing of a long noncoding RNA at the miR-124-1 locus. In human immunodeficiency virus type 1 (HIV-1)-infected cells, obefazimod interacts with the CBC of HIV-1 mRNA and inhibits viral replication by preventing Rev-mediated export of unspliced HIV-1 transcripts to the cytoplasm. Rev facilitates the nuclear export of unspliced or incompletely spliced viral pre-mRNAs, an essential step in HIV-1 replication. In inflammatory conditions, miR-124 reduces the production of various inflammatory mediators, including interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), and C-C motif chemokine 2 (CCL2; MCP-1.). miR-124 plays a critical role in innate and adaptive immune responses and is a critical mediator of cholinergic anti-inflammatory action.

Obefazimod Manufacturers

A Obefazimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Obefazimod, including repackagers and relabelers. The FDA regulates Obefazimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Obefazimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Obefazimod Suppliers

A Obefazimod supplier is an individual or a company that provides Obefazimod active pharmaceutical ingredient (API) or Obefazimod finished formulations upon request. The Obefazimod suppliers may include Obefazimod API manufacturers, exporters, distributors and traders.

Obefazimod GMP

Obefazimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Obefazimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Obefazimod GMP manufacturer or Obefazimod GMP API supplier for your needs.

Obefazimod CoA

A Obefazimod CoA (Certificate of Analysis) is a formal document that attests to Obefazimod's compliance with Obefazimod specifications and serves as a tool for batch-level quality control.

Obefazimod CoA mostly includes findings from lab analyses of a specific batch. For each Obefazimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Obefazimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Obefazimod EP), Obefazimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Obefazimod USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty